PFE Bear Put Spread Strategy

PFE (Pfizer Inc.), in the Healthcare sector, (Drug Manufacturers - General industry), listed on NYSE.

Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and women's health under the Premarin family and Eliquis brands; biologics, small molecules, immunotherapies, and biosimilars under the Ibrance, Xtandi, Sutent, Inlyta, Retacrit, Lorbrena, and Braftovi brands; and sterile injectable and anti-infective medicines, and oral COVID-19 treatment under the Sulperazon, Medrol, Zavicefta, Zithromax, Vfend, Panzyga, and Paxlovid brands. The company also provides medicines and vaccines in various therapeutic areas, such as pneumococcal disease, meningococcal disease, tick-borne encephalitis, and COVID-19 under the Comirnaty/BNT162b2, Nimenrix, FSME/IMMUN-TicoVac, Trumenba, and the Prevnar family brands; biosimilars for chronic immune and inflammatory diseases under the Xeljanz, Enbrel, Inflectra, Eucrisa/Staquis, and Cibinqo brands; and amyloidosis, hemophilia, and endocrine diseases under the Vyndaqel/Vyndamax, BeneFIX, and Genotropin brands. In addition, the company is involved in the contract manufacturing business. It serves wholesalers, retailers, hospitals, clinics, government agencies, pharmacies, and individual provider offices, as well as disease control and prevention centers. The company has collaboration agreements with Bristol-Myers Squibb Company; Astellas Pharma US, Inc.; Myovant Sciences Ltd.; Akcea Therapeutics, Inc; Merck KGaA; Valneva SE; BioNTech SE; and Arvinas, Inc.

PFE (Pfizer Inc.) trades in the Healthcare sector, specifically Drug Manufacturers - General, with a market capitalization of approximately $147.96B, a trailing P/E of 19.72, a beta of 0.31 versus the broader market, a 52-week range of 22.09-28.75, average daily share volume of 38.1M, a public-listing history dating back to 1972, approximately 81K full-time employees. These structural characteristics shape how PFE stock options price implied volatility around earnings windows, capital events, and macro-driven sector rotations.

A beta of 0.31 indicates PFE has historically moved less than the broader market, dampening realized volatility and producing tighter expected-move bands per unit of dollar exposure. PFE pays a dividend, which adjusts put-call parity and shifts the ex-dividend pricing across the listed chain.

What is a bear put spread on PFE?

A bear put spread buys an at-the-money put and sells an out-of-the-money put at a lower strike for defined risk and defined reward bounded by the strike width.

Current PFE snapshot

As of May 15, 2026, spot at $25.30, ATM IV 22.44%, IV rank 28.63%, expected move 6.43%. The bear put spread on PFE below is built from the same end-of-day chain, with strikes snapped to listed contracts and premiums pulled from the bid/ask midpoint at a 28-day expiry.

Why this bear put spread structure on PFE specifically: PFE IV at 22.44% is on the cheap side of its 1-year range, which favors premium-buying structures like a PFE bear put spread, with a market-implied 1-standard-deviation move of approximately 6.43% (roughly $1.63 on the underlying). The 28-day window matched to the front-month expiry keeps theta exposure bounded while still capturing the post-snapshot move; longer-dated PFE expiries trade a higher absolute premium for lower per-day decay. Position sizing on PFE should anchor to the underlying notional of $25.30 per share and to the trader's directional view on PFE stock.

PFE bear put spread setup

The PFE bear put spread below is built from the end-of-day chain, with each option leg priced at the bid/ask midpoint of its listed strike. With PFE near $25.30, the first option leg uses a $25.00 strike; additional legs (when the strategy has them) anchor to spot-relative offsets. Premiums come from the bid/ask midpoint on the listed PFE chain at a 28-day expiry; the cross-strike IV skew is reflected directly in the per-leg values rather than approximated. Quantity sizing assumes one contract per option leg (or 100 PFE shares for the stock leg in covered calls and collars).

ActionTypeStrike / BasisPremium (est)
Buy 1Put$25.00$0.45
Sell 1Put$24.00$0.16

PFE bear put spread risk and reward

Net Premium / Debit
-$28.50
Max Profit (per contract)
$71.50
Max Loss (per contract)
-$28.50
Breakeven(s)
$24.72
Risk / Reward Ratio
2.509

Max profit equals strike width minus net debit times 100; max loss equals net debit times 100. Breakeven is long-put strike minus net debit.

PFE bear put spread payoff curve

Modeled P&L at expiration across a range of underlying prices for the bear put spread on PFE. Each row is one sampled price point from the computed payoff curve; the full curve uses 200 price points internally before being summarized into 10 rows here.

Underlying Price% From SpotP&L at Expiration
$0.01-100.0%+$71.50
$5.60-77.9%+$71.50
$11.20-55.7%+$71.50
$16.79-33.6%+$71.50
$22.38-11.5%+$71.50
$27.97+10.6%-$28.50
$33.57+32.7%-$28.50
$39.16+54.8%-$28.50
$44.75+76.9%-$28.50
$50.35+99.0%-$28.50

When traders use bear put spread on PFE

Bear put spreads on PFE reduce the cost of a bearish PFE stock position by selling a lower-strike put; suited to moderate-decline theses where price reaches but does not vastly exceed the short strike.

PFE thesis for this bear put spread

The market-implied 1-standard-deviation range for PFE extends from approximately $23.67 on the downside to $26.93 on the upside. A PFE bear put spread caps both the risk and the reward of a bearish position; relative to an outright long put on PFE, the spread reduces the cost basis but limits the maximum profit to the strike width minus net debit. Current PFE IV rank near 28.63% sits in the lower third of its 1-year distribution, where IV often re-expands toward the mean; this favors premium-buying structures and disadvantages premium-selling structures on PFE at 22.44%. As a Healthcare name, PFE options can move on sector-level news flow (peer earnings, regulatory updates, industry-specific macro data) in addition to PFE-specific events.

PFE bear put spread positions are structurally moderately bearish; the modeled P&L assumes European-style exercise at expiration and ignores early assignment, transaction costs, dividends paid before expiry on the stock leg (when present), and the bid-ask spread on the listed chain. PFE positions also carry Healthcare sector concentration risk; news flow inside the sector (peer earnings, regulatory shifts, supply-chain headlines) can move PFE alongside the broader basket even when PFE-specific fundamentals are unchanged. Long-premium structures like a bear put spread on PFE are particularly exposed to IV-crush risk through scheduled events (earnings, FDA decisions, central-bank meetings) where IV typically contracts post-event regardless of the directional outcome. Always rebuild the position from current PFE chain quotes before placing a trade.

Frequently asked questions

What is a bear put spread on PFE?
A bear put spread on PFE is the bear put spread strategy applied to PFE (stock). The strategy is structurally moderately bearish: A bear put spread buys an at-the-money put and sells an out-of-the-money put at a lower strike for defined risk and defined reward bounded by the strike width. With PFE stock trading near $25.30, the strikes shown on this page are snapped to the nearest listed PFE chain strike and the premiums come straight from the end-of-day bid/ask midpoint.
How are PFE bear put spread max profit and max loss calculated?
Max profit equals strike width minus net debit times 100; max loss equals net debit times 100. Breakeven is long-put strike minus net debit. For the PFE bear put spread priced from the end-of-day chain at a 30-day expiry (ATM IV 22.44%), the computed maximum profit is $71.50 per contract and the computed maximum loss is -$28.50 per contract. Live intraday quotes will differ as the chain moves through the trading session.
What is the breakeven for a PFE bear put spread?
The breakeven for the PFE bear put spread priced on this page is roughly $24.72 at expiration, derived from end-of-day chain premiums. Breakeven is the underlying price at which the strategy's P&L crosses zero ignoring transaction costs and assignment risk. The current PFE market-implied 1-standard-deviation expected move is approximately 6.43%; if the move sits well outside the breakeven distance, the structure's risk-reward becomes correspondingly tighter.
When should you consider a bear put spread on PFE?
Bear put spreads on PFE reduce the cost of a bearish PFE stock position by selling a lower-strike put; suited to moderate-decline theses where price reaches but does not vastly exceed the short strike.
How does current PFE implied volatility affect this bear put spread?
PFE ATM IV is at 22.44% with IV rank near 28.63%, which is on the low end of its 1-year range. Premium-buying structures (long call, long put, debit spreads) are relatively cheap in this regime; premium-selling structures collect less credit per unit risk.

Related PFE analysis